Zheng C et al. |
Chemoenzymatically synthesized GM3 analogues as potential therapeutic agents to recover nervous functionality after injury by inducing neurite outgrowth. |
2018 |
Eur J Med Chem |
pmid:29407985
|
Bousquet PA et al. |
Hypothesis: Hypoxia induces de novo synthesis of NeuGc gangliosides in humans through CMAH domain substitute. |
2018 |
Biochem. Biophys. Res. Commun. |
pmid:29196263
|
Wegener H et al. |
Human norovirus GII.4(MI001) P dimer binds fucosylated and sialylated carbohydrates. |
2017 |
Glycobiology |
pmid:28973640
|
Komura N et al. |
Syntheses of Fluorescent Gangliosides for the Studies of Raft Domains. |
2017 |
Meth. Enzymol. |
pmid:28935104
|
Valdes-Zayas A et al. |
Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy. |
2017 |
J. Immunother. |
pmid:28604556
|
Park HJ et al. |
Ganglioside GM3 induces cumulus cell apoptosis through inhibition of epidermal growth factor receptor-mediated PI3K/AKT signaling pathways during in vitro maturation of pig oocytes. |
2017 |
Mol. Reprod. Dev. |
pmid:28585705
|
Dufresne M et al. |
Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry. |
2017 |
Anal Bioanal Chem |
pmid:27873002
|
Han YB et al. |
Structural Insights into the Broad Substrate Specificity of a Novel Endoglycoceramidase I Belonging to a New Subfamily of GH5 Glycosidases. |
2017 |
J. Biol. Chem. |
pmid:28179425
|
Choi H et al. |
Monosialyl Ganglioside GM3 Decreases Apolipoprotein B-100 Secretion in Liver Cells. |
2017 |
J. Cell. Biochem. |
pmid:28019668
|
Suzuki KGN et al. |
Development of new ganglioside probes and unraveling of raft domain structure by single-molecule imaging. |
2017 |
Biochim. Biophys. Acta |
pmid:28734966
|
Trilck M et al. |
Diversity of glycosphingolipid GM2 and cholesterol accumulation in NPC1 patient-specific iPSC-derived neurons. |
2017 |
Brain Res. |
pmid:27923633
|
Go S et al. |
Altered expression of ganglioside GM3 molecular species and a potential regulatory role during myoblast differentiation. |
2017 |
J. Biol. Chem. |
pmid:28275055
|
Chan RB et al. |
Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis. |
2017 |
PLoS ONE |
pmid:28212433
|
Matsubara T et al. |
Selective Intracellular Delivery of Ganglioside GM3-Binding Peptide through Caveolae/Raft-Mediated Endocytosis. |
2017 |
Biomacromolecules |
pmid:28051846
|
Dam DH et al. |
Ganglioside GM3 Mediates Glucose-Induced Suppression of IGF-1 Receptor-Rac1 Activation to Inhibit Keratinocyte Motility. |
2017 |
J. Invest. Dermatol. |
pmid:27729281
|
Delannoy CP et al. |
Glycosylation Changes Triggered by the Differentiation of Monocytic THP-1 Cell Line into Macrophages. |
2017 |
J. Proteome Res. |
pmid:27351377
|
Yoshinaga A et al. |
NEU3 inhibitory effect of naringin suppresses cancer cell growth by attenuation of EGFR signaling through GM3 ganglioside accumulation. |
2016 |
Eur. J. Pharmacol. |
pmid:27105818
|
Winner LK et al. |
A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome. |
2016 |
Hum. Gene Ther. |
pmid:26975339
|
Gentilini MV et al. |
The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction. |
2016 |
Cancer Immunol. Immunother. |
pmid:26969612
|
Gabri MR et al. |
Racotumomab for treating lung cancer and pediatric refractory malignancies. |
2016 |
Expert Opin Biol Ther |
pmid:26903265
|